Briley-Saebo K - Search Results

1

Quantification of renal perfusion using an intravascular contrast agent (part 1): results in a canine model.

Aumann S, Schoenberg SO, Just A, Briley-Saebo K, Bjørnerud A, Bock M, Brix G. Aumann S, et al. Magn Reson Med. 2003 Feb;49(2):276-87. doi: 10.1002/mrm.10380. Magn Reson Med. 2003. PMID: 12541248 Free article.

2

Assessment of T1 and T2* effects in vivo and ex vivo using iron oxide nanoparticles in steady state--dependence on blood volume and water exchange.

Bjørnerud A, Johansson LO, Briley-Saebø K, Ahlström HK. Bjørnerud A, et al. Magn Reson Med. 2002 Mar;47(3):461-71. doi: 10.1002/mrm.10066. Magn Reson Med. 2002. PMID: 11870832 Free article.

3

Long-term imaging effects in rat liver after a single injection of an iron oxide nanoparticle based MR contrast agent.

Briley-Saebø K, Hustvedt SO, Haldorsen A, Bjørnerud A. Briley-Saebø K, et al. J Magn Reson Imaging. 2004 Oct;20(4):622-31. doi: 10.1002/jmri.20175. J Magn Reson Imaging. 2004. PMID: 15390223

4

Effect of NC100150 injection on the (1)H NMR linewidth of human whole blood ex vivo: dependency on blood oxygen tension.

Bjørnerud A, Briley-Saebø K, Johansson LO, Kellar KE. Bjørnerud A, et al. Magn Reson Med. 2000 Nov;44(5):803-7. doi: 10.1002/1522-2594(200011)44:5<803::aid-mrm19>3.0.co;2-k. Magn Reson Med. 2000. PMID: 11064416 Free article.

5

Intravascular contrast agent-enhanced MRI measuring contrast clearance and tumor blood volume and the effects of vascular modifiers in an experimental tumor.

Bentzen L, Vestergaard-Poulsen P, Nielsen T, Overgaard J, Bjørnerud A, Briley-Saebø K, Horsman MR, Ostergaard L. Bentzen L, et al. Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1208-15. doi: 10.1016/j.ijrobp.2004.12.020. Int J Radiat Oncol Biol Phys. 2005. PMID: 15752903

6

NC100150 Injection, a preparation of optimized iron oxide nanoparticles for positive-contrast MR angiography.

Kellar KE, Fujii DK, Gunther WH, Briley-Saebø K, Bjørnerud A, Spiller M, Koenig SH. Kellar KE, et al. J Magn Reson Imaging. 2000 May;11(5):488-94. doi: 10.1002/(sici)1522-2586(200005)11:5<488::aid-jmri4>3.0.co;2-v. J Magn Reson Imaging. 2000. PMID: 10813858

7

Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: implications for magnetic resonance imaging.

Briley-Saebo K, Bjørnerud A, Grant D, Ahlstrom H, Berg T, Kindberg GM. Briley-Saebo K, et al. Cell Tissue Res. 2004 Jun;316(3):315-23. doi: 10.1007/s00441-004-0884-8. Epub 2004 Apr 23. Cell Tissue Res. 2004. PMID: 15103550

8

Clearance of iron oxide particles in rat liver: effect of hydrated particle size and coating material on liver metabolism.

Briley-Saebo KC, Johansson LO, Hustvedt SO, Haldorsen AG, Bjørnerud A, Fayad ZA, Ahlstrom HK. Briley-Saebo KC, et al. Invest Radiol. 2006 Jul;41(7):560-71. doi: 10.1097/01.rli.0000221321.90261.09. Invest Radiol. 2006. PMID: 16772849

9

Fractionated Feridex and positive contrast: in vivo MR imaging of atherosclerosis.

Briley-Saebo KC, Mani V, Hyafil F, Cornily JC, Fayad ZA. Briley-Saebo KC, et al. Magn Reson Med. 2008 Apr;59(4):721-30. doi: 10.1002/mrm.21541. Magn Reson Med. 2008. PMID: 18383304 Free article.

10

Gradient echo acquisition for superparamagnetic particles with positive contrast (GRASP): sequence characterization in membrane and glass superparamagnetic iron oxide phantoms at 1.5T and 3T.

Mani V, Briley-Saebo KC, Itskovich VV, Samber DD, Fayad ZA. Mani V, et al. Magn Reson Med. 2006 Jan;55(1):126-35. doi: 10.1002/mrm.20739. Magn Reson Med. 2006. PMID: 16342148 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters